126 related articles for article (PubMed ID: 15057163)
21. Letrozole in breast cancer.
Buzdar AU
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14960751
[No Abstract] [Full Text] [Related]
22. Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
[No Abstract] [Full Text] [Related]
23. Drug update: letrozole: A new aromatase inhibitor for metastatic breast cancer.
Mays-Holland T
Cancer Pract; 1998; 6(6):349-52. PubMed ID: 9824427
[No Abstract] [Full Text] [Related]
24. Breast-cancer drug letrozole picks up where tamoxifen leaves off. But we don't know who stands to benefit the most from this follow-up approach.
Runowicz CD
Health News; 2003 Dec; 9(12):4-5. PubMed ID: 14679962
[No Abstract] [Full Text] [Related]
25. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
[TBL] [Abstract][Full Text] [Related]
26. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
[TBL] [Abstract][Full Text] [Related]
27. Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer.
Piccart MJ; Cardoso F; Atalay G
Eur J Cancer; 2002 Nov; 38 Suppl 6():S52-4. PubMed ID: 12409074
[No Abstract] [Full Text] [Related]
28. Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.
Burstein HJ
N Engl J Med; 2003 Nov; 349(19):1857-9. PubMed ID: 14551340
[No Abstract] [Full Text] [Related]
29. Letrozole: advancing hormone therapy in breast cancer.
Lee RJ; Armstrong AC; Wardley AM
Womens Health (Lond); 2012 Nov; 8(6):611-8. PubMed ID: 23181527
[TBL] [Abstract][Full Text] [Related]
30. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
Wardley AM
Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
[TBL] [Abstract][Full Text] [Related]
31. Letrozole in postmenopausal hormone-responsive early-stage breast cancer: a viewpoint by Gerald M. Higa.
Higa GM
Drugs; 2006; 66(3):363-4. PubMed ID: 16526828
[No Abstract] [Full Text] [Related]
32. Letrozole for the management of breast cancer.
Goss PE; Smith RE
Expert Rev Anticancer Ther; 2002 Jun; 2(3):249-60. PubMed ID: 12113048
[TBL] [Abstract][Full Text] [Related]
33. Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.
Buzdar AU
J Clin Oncol; 2007 May; 25(15):2147-8; author reply 2148. PubMed ID: 17513830
[No Abstract] [Full Text] [Related]
34. Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
Ravdin P
Lancet; 2002 Jun; 359(9324):2126-7. PubMed ID: 12090973
[No Abstract] [Full Text] [Related]
35. New generation aromatase inhibitors--from the advanced to the adjuvant setting.
Buzdar AU
Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S13-7; discussion S33-5. PubMed ID: 12353818
[TBL] [Abstract][Full Text] [Related]
36. Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients.
Trunet PF; Bhatnagar AS; Chaudri HA; Hornberger U
Acta Oncol; 1996; 35 Suppl 5():15-8. PubMed ID: 9142959
[TBL] [Abstract][Full Text] [Related]
37. Beating breast cancer.
Fricker J
Nurs Stand; 2004 Aug 11-17; 18(48):15. PubMed ID: 15366393
[No Abstract] [Full Text] [Related]
38. [Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer. The example of the MA-17 study].
Forciniti S
Suppl Tumori; 2004; 3(4):S25-6. PubMed ID: 15206205
[No Abstract] [Full Text] [Related]
39. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
Bergmann L
Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
[No Abstract] [Full Text] [Related]
40. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
Buzdar AU; Robertson JF; Eiermann W; Nabholtz JM
Cancer; 2002 Nov; 95(9):2006-16. PubMed ID: 12404296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]